These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34614191)

  • 21. Highly efficient genome editing in N. gerenzanensis using an inducible CRISPR/Cas9-RecA system.
    Yue X; Xia T; Wang S; Dong H; Li Y
    Biotechnol Lett; 2020 Sep; 42(9):1699-1706. PubMed ID: 32314149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-FRT targets shared sites in a knock-out collection for off-the-shelf genome editing.
    Swings T; Marciano DC; Atri B; Bosserman RE; Wang C; Leysen M; Bonte C; Schalck T; Furey I; Van den Bergh B; Verstraeten N; Christie PJ; Herman C; Lichtarge O; Michiels J
    Nat Commun; 2018 Jun; 9(1):2231. PubMed ID: 29884781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unpredicted central inversion in a sgRNA flanked by inverted repeats.
    Wang G; Sukumar S
    Mol Biol Rep; 2020 Aug; 47(8):6375-6378. PubMed ID: 32424520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial Genome Editing with CRISPR-Cas9: Deletion, Integration, Single Nucleotide Modification, and Desirable "Clean" Mutant Selection in Clostridium beijerinckii as an Example.
    Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
    ACS Synth Biol; 2016 Jul; 5(7):721-32. PubMed ID: 27115041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in utilizing the endogenous CRISPR-Cas system for genome editing of lactic acid bacteria].
    Zhu Q; Xu C; Zhang S; Xie N; Pang X; Lü J
    Sheng Wu Gong Cheng Xue Bao; 2022 Jul; 38(7):2447-2458. PubMed ID: 35871616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical transformation mediated CRISPR/Cas9 genome editing in Escherichia coli.
    Sun D; Wang L; Mao X; Fei M; Chen Y; Shen M; Qiu J
    Biotechnol Lett; 2019 Feb; 41(2):293-303. PubMed ID: 30547274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic Genome Editing Using In Vivo Synthesized Donor ssDNA in
    Hao M; Wang Z; Qiao H; Yin P; Qiao J; Qi H
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portable bacterial CRISPR transcriptional activation enables metabolic engineering in Pseudomonas putida.
    Kiattisewee C; Dong C; Fontana J; Sugianto W; Peralta-Yahya P; Carothers JM; Zalatan JG
    Metab Eng; 2021 Jul; 66():283-295. PubMed ID: 33930546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
    Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
    Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New CRISPR-Cas systems from uncultivated microbes.
    Burstein D; Harrington LB; Strutt SC; Probst AJ; Anantharaman K; Thomas BC; Doudna JA; Banfield JF
    Nature; 2017 Feb; 542(7640):237-241. PubMed ID: 28005056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Repair of Double-Stranded DNA Breaks Generated by CRISPR-Cas9 in Pseudomonas putida KT2440].
    Sharaev N; Chacon-Machado L; Musharova O; Savitskaya E; Severinov K
    Mol Biol (Mosk); 2022; 56(6):914. PubMed ID: 36475478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
    Koonin EV; Gootenberg JS; Abudayyeh OO
    Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible CRISPR/Cas9 Allows for Multiplexed and Rapidly Segregated Single-Target Genome Editing in
    Cengic I; Cañadas IC; Minton NP; Hudson EP
    ACS Synth Biol; 2022 Sep; 11(9):3100-3113. PubMed ID: 35969224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deaminase-mediated multiplex genome editing in Escherichia coli.
    Banno S; Nishida K; Arazoe T; Mitsunobu H; Kondo A
    Nat Microbiol; 2018 Apr; 3(4):423-429. PubMed ID: 29403014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing.
    Tong Y; Jørgensen TS; Whitford CM; Weber T; Lee SY
    Nat Commun; 2021 Sep; 12(1):5206. PubMed ID: 34471126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A compact Cascade-Cas3 system for targeted genome engineering.
    Csörgő B; León LM; Chau-Ly IJ; Vasquez-Rifo A; Berry JD; Mahendra C; Crawford ED; Lewis JD; Bondy-Denomy J
    Nat Methods; 2020 Dec; 17(12):1183-1190. PubMed ID: 33077967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.